(Q40746622)

English

Onset and reversibility of changes in secretory function and composition of isolated rat pancreatic islets following long-term administration of high or low tolbutamide doses

scientific article published on January 1, 1977

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Onset and reversibility of changes in secretory function and composition of isolated rat pancreatic islets following long-term administration of high or low tolbutamide doses (English)

reason for preferred rank

most precise value

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

Onset and reversibility of changes in secretory function and composition of isolated rat pancreatic islets following long-term administrationof high or low tolbutamide doses (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319321

14 March 2023

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

author name string

P. Schauder

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319321

14 March 2023

J. Arends

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319321

14 March 2023

H. Frerichs

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A319321

14 March 2023

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=319321

14 March 2023

publication date

1 January 1977

1 reference

Europe PubMed Central

23 September 2017

full work available at URL

https://api.elsevier.com/content/article/PII:0026049577901226?httpAccept=text/xml

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

https://api.elsevier.com/content/article/PII:0026049577901226?httpAccept=text/plain

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

1 reference

Europe PubMed Central

23 September 2017

26

1 reference

Europe PubMed Central

23 September 2017

1

1 reference

Europe PubMed Central

23 September 2017

9-15

1 reference

Europe PubMed Central

23 September 2017

Appraisal of the Extrapancreatic Actions of Sulfonylureas

2

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

Effect of Chlorpropamide on Serum Glucose and Immunoreactive Insulin Concentrations in Patients with Maturity-onset Diabetes Mellitus

3

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

The effects of long-term acetohexamide treatment on pancreatic islet cell function in maturity-onset diabetes

5

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

The pattern of rsponse of plasma insulin and glucose to meals and fasting during chlorpropamide therapy.

6

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels

7

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

The stimulatory effect on insulin secretion in long-term tolbutamide treatment. Immunological determinations of urinary- and serum insulin

8

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

Morphologic changes associated with sulfonylurea therapy

9

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)

17

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

Reduction in the Activity of the Pancreatic Islets Induced in Normal Rodents by Prolonged Treatment with Derivatives of Sulfonylurea

19

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

Effect of the daily injection of tolbutamide into pregnant rats on the pancreatic insulin content of their offspring

20

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

An inhibitory effect of tolbutamide and glibenclamide (glyburide) on the pancreatic islets of normal animals

21

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

Tolbutamide-induced changes of the DNA, protein and insulin content and the secretory activity of isolated rat pancreatic islets

22

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas

23

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

Cytochalasin B: Inhibition of glucose-induced insulin release from isolated rat pancreatic islets

25

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

[On radio-immunologic determination of insulin in blood].

26

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

Effects of pregnancy in the rat on the size and insulin secretory response of the islets of Langerhans

27

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

Ultrastructure of beta-cells during the dynamic response to glucose and tolbutamide in vitro

29

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

The effect of tolbutamide and glibenclamide on the incorporation of [3 H]leucine and on the conversion of proinsulin to insulin in isolated pancreatic islets

32

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

The stimulation of insulin release by essential amino acids from rabbit pancreas in vitro

33

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

Effects of L-leucine and alpha-ketoisocaproic acid upon insulin secretion and metabolism of isolated pancreatic islets

34

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

A COMPARISON OF LEUCINE- AND ACETOACETATE-INDUCED HYPOGLYCEMIA IN MAN.

35

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

In vitro stimulation of insulin release by non-metabolizable, transport-specific amino acids

37

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

Inhibition of cyclic 3',5'-AMP phosphodiesterase in islet cells and other tissues by tolbutamide.

39

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

Glucose-mediated insulin release: 3',5' cAMP phosphodiesterase

40

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

The role of adenosine 3':5'-cyclic monophosphate in the regulation of insulin release. Properties of islet-cell adenosine 3':5'-cyclic monophosphate phosphodiesterase

41

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

5′-Guanylylimidodiphosphate: A modulator of glucagon-induced insulin release from isolated rat pancreatic islets

44

1 reference

10.1016/0026-0495(77)90122-6

https://api.crossref.org/works/10.1016/0026-0495(77)90122-6

14 March 2023

Identifiers

10.1016/0026-0495(77)90122-6

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40746622&oldid=2088513879"